Method for producing intermediates for the production of novel macrocyclic compounds such as argylin and its derivatives, which are inhibitors of p27 proteasome degradation, and use of the macrocyclic compounds
The present invention relates to the use of particular macrocycles that are inhibitors of the proteasomic degradation of p27, in particular argyrin and derivatives thereof, for a treatment in a variety of conditions, such as the induction of immunotolerance, autoimmune diseases, bacterial infections, and proliferative diseases, such as cancers.